| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human RTL1 recombinant protein (Position: H446-R1327) was used as the immunogen for the RTL1 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
RTL1 Antibody / Retrotransposon like 1 is an antibody targeting RTL1. Host: Rabbit. Polyclonal. Format: Lyophilized. Applications: WB, FACS, ELISA.
Key elements and design rationale
- Target: RTL1.
- Immunogen: E.coli-derived human RTL1 recombinant protein (Position: H446-R1327) was used as the immunogen for the RTL1 antibody..
- Species reactivity: Human, Mouse, Rat.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
RTL1 antibody detects Retrotransposon-derived protein 1, encoded by the RTL1 gene on chromosome 14q32. RTL1 antibody is commonly used in research on placental biology, imprinting, and developmental regulation.
Common research applications
- WB: relative abundance and band pattern assessment using appropriate controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
